|
HBIS Company Limited (000709.SZ) DCF -Bewertung
CN | Basic Materials | Steel | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Hbis Company Limited (000709.SZ) Bundle
Vereinfachen Sie die Bewertung der HBIS Company Limited (000709SZ) mit diesem anpassbaren DCF -Taschenrechner! Mit Real HBIS Company Limited (000709SZ) Finanzdaten und einstellbaren Prognoseeingaben können Sie Szenarien testen und die beizulegende Zeitwerte von HBIS Company Limited (000709SZ) in Minuten aufdecken.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 121,495.4 | 107,657.1 | 149,626.2 | 143,470.1 | 122,743.9 | 125,516.0 | 128,350.6 | 131,249.2 | 134,213.3 | 137,244.3 |
| Revenue Growth, % | 0 | -11.39 | 38.98 | -4.11 | -14.45 | 2.26 | 2.26 | 2.26 | 2.26 | 2.26 |
| EBITDA | 14,785.8 | 13,688.1 | 17,107.9 | 14,187.7 | 13,820.7 | 14,426.0 | 14,751.8 | 15,085.0 | 15,425.6 | 15,774.0 |
| EBITDA, % | 12.17 | 12.71 | 11.43 | 9.89 | 11.26 | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 |
| Depreciation | 7,524.6 | 6,884.9 | 7,963.2 | 7,644.7 | 7,333.9 | 7,333.6 | 7,499.3 | 7,668.6 | 7,841.8 | 8,018.9 |
| Depreciation, % | 6.19 | 6.4 | 5.32 | 5.33 | 5.97 | 5.84 | 5.84 | 5.84 | 5.84 | 5.84 |
| EBIT | 7,261.2 | 6,803.2 | 9,144.7 | 6,543.0 | 6,486.8 | 7,092.4 | 7,252.6 | 7,416.3 | 7,583.8 | 7,755.1 |
| EBIT, % | 5.98 | 6.32 | 6.11 | 4.56 | 5.28 | 5.65 | 5.65 | 5.65 | 5.65 | 5.65 |
| Total Cash | 24,576.0 | 28,419.9 | 35,016.5 | 34,480.1 | 46,091.2 | 33,039.0 | 33,785.1 | 34,548.1 | 35,328.3 | 36,126.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 18,696.5 | 14,719.0 | 14,555.2 | 8,857.1 | 4,181.1 | 12,142.0 | 12,416.2 | 12,696.6 | 12,983.3 | 13,276.5 |
| Account Receivables, % | 15.39 | 13.67 | 9.73 | 6.17 | 3.41 | 9.67 | 9.67 | 9.67 | 9.67 | 9.67 |
| Inventories | 21,717.8 | 20,582.8 | 19,384.5 | 22,116.8 | 20,246.2 | 20,549.4 | 21,013.5 | 21,488.1 | 21,973.4 | 22,469.6 |
| Inventories, % | 17.88 | 19.12 | 12.96 | 15.42 | 16.49 | 16.37 | 16.37 | 16.37 | 16.37 | 16.37 |
| Accounts Payable | 48,981.5 | 54,446.0 | 47,630.8 | 49,397.3 | 50,896.9 | 49,859.6 | 50,985.6 | 52,137.0 | 53,314.5 | 54,518.5 |
| Accounts Payable, % | 40.32 | 50.57 | 31.83 | 34.43 | 41.47 | 39.72 | 39.72 | 39.72 | 39.72 | 39.72 |
| Capital Expenditure | -10,967.9 | -11,227.8 | -9,799.6 | -21,260.2 | -17,558.4 | -13,839.3 | -14,151.8 | -14,471.4 | -14,798.2 | -15,132.4 |
| Capital Expenditure, % | -9.03 | -10.43 | -6.55 | -14.82 | -14.3 | -11.03 | -11.03 | -11.03 | -11.03 | -11.03 |
| Tax Rate, % | 19.48 | 19.48 | 19.48 | 19.48 | 19.48 | 19.48 | 19.48 | 19.48 | 19.48 | 19.48 |
| EBITAT | 5,135.9 | 4,781.3 | 6,701.8 | 5,680.4 | 5,223.2 | 5,413.4 | 5,535.6 | 5,660.7 | 5,788.5 | 5,919.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 10,259.9 | 11,015.4 | -587.8 | -3,202.7 | 3,044.9 | -10,393.7 | -729.2 | -745.6 | -762.5 | -779.7 |
| WACC, % | 4.79 | 4.76 | 4.91 | 5.58 | 5.27 | 5.06 | 5.06 | 5.06 | 5.06 | 5.06 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -12,431.2 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | -807 | |||||||||
| Terminal Value | -51,620 | |||||||||
| Present Terminal Value | -40,324 | |||||||||
| Enterprise Value | -52,755 | |||||||||
| Net Debt | 61,872 | |||||||||
| Equity Value | -114,627 | |||||||||
| Diluted Shares Outstanding, MM | 12,041 | |||||||||
| Equity Value Per Share | -9.52 |
What You Will Receive
- Genuine Hbis Data: Preloaded financial metrics – encompassing revenue to EBIT – derived from real and projected numbers.
- Comprehensive Customization: Modify all essential parameters (highlighted cells) such as WACC, growth percentage, and tax rates.
- Immediate Valuation Adjustments: Automatic recalculations to assess the effects of changes on Hbis Company Limited’s fair value.
- Flexible Excel Template: Designed for easy modifications, scenario evaluation, and in-depth forecasting.
- Efficient and Precise: Bypass the hassle of creating models from scratch while ensuring accuracy and adaptability.
Key Features
- Pre-Loaded Data: Hbis Company Limited’s historical financial statements and pre-filled forecasts.
- Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Instant Results: Watch Hbis Company Limited’s intrinsic value update in real time.
- Clear Visual Outputs: Dashboard charts present valuation results and essential metrics.
- Built for Accuracy: A professional-grade tool designed for analysts, investors, and finance professionals.
How It Operates
- Download: Obtain the pre-made Excel file featuring Hbis Company Limited’s (000709SZ) financial data.
- Customize: Modify forecasts, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and instantly compare the results.
- Make Decisions: Utilize the valuation findings to inform your investment strategy.
Why Opt for the HBIS Company Limited Calculator?
- Time Efficient: Eliminate the hassle of building a DCF model from the ground up – our tool is ready for immediate use.
- Enhanced Precision: Dependable financial data and formulas minimize errors in your valuations.
- Completely Customizable: Adjust the model to align with your specific assumptions and forecasts.
- User-Friendly: Intuitive charts and outputs simplify result interpretation.
- Endorsed by Professionals: Crafted for experts who prioritize both accuracy and ease of use.
Who Should Consider Using This Product?
- Individual Investors: Gain insights for making informed decisions regarding buying or selling Hbis Company Limited (000709SZ) stock.
- Financial Analysts: Enhance valuation workflows with comprehensive financial models tailored for Hbis Company Limited (000709SZ).
- Consultants: Provide clients with precise and timely valuation insights related to Hbis Company Limited (000709SZ).
- Business Owners: Learn how large enterprises, such as Hbis Company Limited (000709SZ), are valued to inform your business strategies.
- Finance Students: Explore valuation methodologies through practical examples and real-world data related to Hbis Company Limited (000709SZ).
Contents of the Template
- Detailed DCF Model: User-friendly template featuring in-depth valuation computations.
- Real-World Data: Historical and forecasted financials for Hbis Company Limited (000709SZ) included for analysis.
- Adjustable Assumptions: Modify WACC, growth rates, and tax estimates to explore various scenarios.
- Financial Statements: Comprehensive annual and quarterly financial data for enhanced analysis.
- Key Financial Ratios: Integrated assessment tools for evaluating profitability, efficiency, and financial leverage.
- Interactive Dashboard: Visual charts and tables offering clear, actionable insights.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.